APA (7th ed.) Citation

Hamberg, V., Sohrabian, A., Volkmann, E. R., Wildt, M., Löfdahl, A., Wuttge, D. M., . . . Andréasson, K. (2023). Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study. Arthritis research & therapy, 25(1), 1-13. https://doi.org/10.1186/s13075-023-03141-4

Chicago Style (17th ed.) Citation

Hamberg, Viggo, et al. "Anti-Ro52 Positivity Is Associated with Progressive Interstitial Lung Disease in Systemic Sclerosis—an Exploratory Study." Arthritis Research & Therapy 25, no. 1 (2023): 1-13. https://doi.org/10.1186/s13075-023-03141-4.

MLA (9th ed.) Citation

Hamberg, Viggo, et al. "Anti-Ro52 Positivity Is Associated with Progressive Interstitial Lung Disease in Systemic Sclerosis—an Exploratory Study." Arthritis Research & Therapy, vol. 25, no. 1, 2023, pp. 1-13, https://doi.org/10.1186/s13075-023-03141-4.